Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...
BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...
News-Medical.Net on MSN12h
Researchers develop tool to enhance NK cells against cancerA team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...
Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...
SAN FRANCISCO and SUZHOU, China, March 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...
Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...
Stein, MD, professor and co-director of the Acute Leukemia Program at City of Hope in Duarte, California, provides deeper insight into the trial design and key findings in an interview with Targeted ...
Professor Janice Walshe, a medical oncologist, explains how the diagnosis process works when it comes to breast cancer, as ...
The conversion from accelerated approval to traditional approval was supported by data from the phase 3 KEYNOTE-811 trial.
The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback